Comparison Of ALT In Type 2 Diabetics with And Without Fatty Liver Disease by Kausar Malik, Faiza Batool, Lubna Meraj, Shazia Saddiq, Abrar Akbar, Hina Hanif Mughal

“…Conclusion: Fatty liver disease is more common in Type 2 diabetic patients with uncontrolled blood sugar. …”
Get full text

Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD) by Yusri Diane Jurnalis, Yorva Sayoeti, Elfitrimelly .

“…<p>Abstrak<br />Nonalcoholic Fatty Liver Disease (NAFLD) merupakan penyebab tersering penyakit hati kronik pada anak dan remaja diseluruh dunia. …”
Get full text

Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease by Yang Wang, Xiaohuan Yang, Sisi Wang

Subjects: Get full text

Clinical and morphological features of gastroduodenal pathology at alcohol-induced liver disease by I. V. Kozlova, M. A. Suschenko

Subjects: “…alcohol-induced liver disease…”
Get full text

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications by Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan

“…Nonalcoholic fatty liver disease (NAFLD) has a rising prevalence worldwide. …”
Get full text

Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease by M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. A. Gromov

Subjects: “…fatty liver disease…”
Get full text

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD) by Parthana Rani Sutradhar, Nahida Sultana, Afzalun Nessa

Get full text

Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control by Yun Gao, Xiushan Yin, Xiaomeng Ren

“…The chronic liver diseases will slowly develop into liver fibrosis, cirrhosis, and even liver cancer if no proper control is performed with high efficiency. …”
Get full text

Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease by Sitong Yi, Qingwei Cong, Ying Zhu, Qiumin Xu

“…Metabolic-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease worldwide. …”
Get full text

Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease by Tommaso Mello, Simone Polvani, Andrea Galli

“…A growing number of new studies demonstrate that nuclear receptors are involved in the development of alcoholic liver disease (ALD). Ethanol metabolism and RXR/PPAR functions are tightly interconnected in the liver. …”
Get full text

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021 by Gong Feng, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz, Vincent Wai-Sun Wong, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Jerome Boursier, George Papatheodoridis, Mohamed El-Kassas, Nahum Méndez-Sánchez, Silvia Sookoian, Laurent Castera, Wah-Kheong Chan, Feng Ye, Sombat Treeprasertsuk, Helena Cortez-Pinto, Hon Ho Yu, Won Kim, Manuel Romero-Gómez, Atsushi Nakajima, Khin Maung Win, Seung Up Kim, Adriaan G. Holleboom, Giada Sebastiani, Ponsiano Ocama, John D. Ryan, Monica Lupșor-Platon, Hasmik Ghazinyan, Mamun Al-Mahtab, Saeed Hamid, Nilanka Perera, Khalid A. Alswat, Qiuwei Pan, Michelle T. Long, Vasily Isakov, Man Mi, Marco Arrese, Arun J. Sanyal, Shiv Kumar Sarin, Nathalie Carvalho Leite, Luca Valenti, Philip N. Newsome, Hannes Hagström, Salvatore Petta, Hannele Yki-Järvinen, Jörn M. Schattenberg, Marlen I. Castellanos Fernández, Isabelle A. Leclercq, Gulnara Aghayeva, Abdel-Naser Elzouki, Ali Tumi, Ala I. Sharara, Asma Labidi, Faisal M. Sanai, Khaled Matar, Maen Al-Mattooq, Maisam Waid Akroush, Mustapha Benazzouz, Nabil Debzi, Maryam Alkhatry, Salma Barakat, Said A. Al-Busafi, John Rwegasha, Wah Yang, Agyei Adwoa, Christopher Kenneth Opio, Mohammadjavad Sotoudeheian, Yu Jun Wong, Jacob George, Ming-Hua Zheng

Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text

A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases by Yingying Zhao, Huichun Xing

“…The present article reviews the correlation between DM and liver diseases to give an update of the management of DM rooted by viral liver diseases.…”
Get full text

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases by O. E. Nikiforova, Ye. N. Bessonova, O. M. Lesnyak, O. A. Stroganova

“…To study efficacy of albumin dialysis (MARS) at complications of end-stage liver diseases having various etiology.Material and methods. …”
Get full text

The Role of Interventional Endoscopic Ultrasound in Liver Diseases: What Have We Learnt? by Cosmas Rinaldi A. Lesmana, Maria Satya Paramitha, Rino A. Gani

“…Chronic liver disease (CLD) is still a major problem, where the disease progression will lead to liver cirrhosis (LC) or hepatocellular carcinoma (HCC). …”
Get full text

The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies by Hessam Yaghmaei, Amirhossein Bahanesteh, Masood Soltanipur, Sobhan Takaloo, Mahdi Rezaei, Seyed Davar Siadat

“…One of the most common chronic liver diseases is nonalcoholic fatty liver disease (NAFLD), which affects many people around the world. …”
Get full text

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by M. V. Mayevskaya, V. T. Ivashkin, V. D. Lunkov, S. P. Kryzhanovskiy, I. Yu. Pirogova, Ch. S. Pavlov, M. S. Zharkova, A. G. Beniashvili, M. A. Morozova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease by Seon Young Ahn, Suk Bae Kim, Il Han Song

“…Nonalcoholic fatty liver disease (NAFLD) may develop into liver cirrhosis and hepatocellular carcinoma (HCC). …”
Get full text

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease by Roger F. Butterworth, Ali Canbay

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease by Wendy A. Henderson, Angela C. Martino, Noriko Kitamura, Kevin H. Kim, Judith A. Erlen

“…Persons living with human immunodeficiency virus (HIV) are living longer; therefore, they are more likely to suffer significant morbidity due to potentially treatable liver diseases. Clinical evidence suggests that the growing number of individuals living with HIV and liver disease may have a poorer health-related quality of life (HRQOL) than persons living with HIV who do not have comorbid liver disease. …”
Get full text

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease by Hannes Hagström, Olof Elfwén, Rolf Hultcrantz, Per Stål

“…Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease globally. …”
Get full text